Hemodynamic Ramp Test in Cardiogenic Shock Supported by Microaxial Flow Pump: Protocol Description, Feasibility, and...

Area of Science:

• Cardiology
• Biomedical Engineering

Background:

• Limited evidence-based protocols exist for weaning microaxial flow pumps (MAFP).
• Standardization of weaning protocols is crucial for patient safety and effective treatment.

Purpose of the Study:

• To standardize and evaluate the feasibility of an Impella ramp test for MAFP weaning.
• To assess the hemodynamic changes during the ramp test in cardiogenic shock patients.

Main Methods:

• A prospective, single-center study involving 54 cardiogenic shock patients.
• Implementation of a stepwise Impella ramp test from P8 to P2 with continuous hemodynamic monitoring.
• Recording of systemic arterial pulse pressure (SAPP), cardiac power output (CPO), and pulmonary artery wedge pressure (PAWP).

Main Results:

• The Impella ramp test was completed by 85% of patients, demonstrating feasibility and safety.
• Hemodynamic parameters showed significant changes: SAPP increased (12.2 mm Hg), CPO decreased (0.09 W), and PAWP increased (2.5 mm Hg).
• Impella 5.5 patients exhibited greater flow reduction and hemodynamic shifts compared to Impella CP.

Conclusions:

• The Impella ramp test is a safe and feasible protocol for assessing hemodynamic response during MAFP weaning.
• The test provides valuable quantitative data to inform individualized weaning strategies and clinical decision-making.
• Further research can refine MAFP weaning protocols based on these hemodynamic insights.